Champions Oncology (CSBR) Return on Assets (2011 - 2026)
Champions Oncology (CSBR) recorded quarterly Return on Assets of 0.0% in Q1 2026, down 199.83% quarter-over-quarter from 0.0% in Q4 2025, and little changed on a YoY basis from 0.0% in Q1 2025.
Champions Oncology (CSBR) Return on Assets (2011 - 2026) Analysis & Trends
Champions Oncology's Return on Assets history runs 16 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Jan 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets was 0.0% for Q1 2026 at Champions Oncology, down from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2025 to a low of 0.0% in Q1 2024.
- Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
- The sharpest annual moves came in 2022 and 2025: Return on Assets changed 0 bps in 2022, then gained 1 bps in 2025.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then plunged by 10948 bps to 0.0% in 2023, then surged by 93 bps to 0.0% in 2024, then soared by 436 bps to 0.0% in 2025, then plunged by 200 bps to 0.0% in 2026.
- The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -0.01% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.01% |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 0.00% |
| Oct 31, 2025 | 0.00% |
| Jul 31, 2025 | 0.00% |
| Apr 30, 2025 | 0.00% |
| Jan 31, 2025 | 0.00% |
| Oct 31, 2024 | 0.00% |
| Jul 31, 2024 | 0.00% |
| Apr 30, 2024 | 0.00% |
| Jan 31, 2024 | 0.00% |
| Oct 31, 2023 | 0.00% |
| Jul 31, 2023 | 0.00% |
| Apr 30, 2023 | 0.00% |
| Jan 31, 2023 | 0.00% |
| Oct 31, 2022 | 0.00% |
| Jul 31, 2022 | 0.00% |
| Apr 30, 2022 | 0.00% |
| Jan 31, 2022 | 0.00% |
| Oct 31, 2021 | 0.00% |
| Jul 31, 2021 | 0.00% |
| Apr 30, 2021 | 0.00% |